-
Symbol
-
BRTX on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.0001 par value
-
Latest Disclosed Shares Owned
-
1,236,809 shares
-
Security Ownership %
-
16%
ALSTODT LANCE ownership in BioRestorative Therapies, Inc. Common Stock, $0.0001 par value (BRTX)
19 Feb 2025 - ALSTODT LANCE has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,236,809 shares of BioRestorative Therapies, Inc. Common Stock, $0.0001 par value (BRTX).
This represents 16% ownership of the company.
This is the first filing by ALSTODT LANCE disclosing ownership of BioRestorative Therapies, Inc. Common Stock, $0.0001 par value (BRTX).